Table: Jcr Pharmaceuticals -2024/25 parent results

JCR Pharmaceuticals

13/05/2025 08:03

May 13 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             33.07           42.87                                
                 (-22.9 pct)     (+24.8 pct)                             
  Operating       loss 6.90          7.55                                
                                 (+48.2 pct)                             
  Recurring       loss 7.57          8.05                                
                                 (+52.3 pct)                             
  Net             loss 4.75          6.36                                
                                 (+72.6 pct)                             
  EPS          loss 38.33 yen     51.00 yen                              
  EPS Diluted                     50.76 yen                              
  Ann Div         20.00 yen       20.00 yen      20.00 yen               
  -Q2 Div         10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div         10.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T